Daclizumab (anti-CD25) in multiple sclerosis.

Pfender, Nikolai; Martin, Roland

Pfender, Nikolai; Martin, Roland.

Afiliação

Pfender N; Neuroimmunology and MS Research, Department of Neurology, University Hospital Zurich, University Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland. Electronic address: nikolai.pfender@usz.ch.
Martin R; Neuroimmunology and MS Research, Department of Neurology, University Hospital Zurich, University Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland. Electronic address: roland.martin@usz.ch.

Exp Neurol ; 262 Pt A: 44-51, 2014 Dec.

Article em En | MEDLINE | ID: mdl-24768797

Assuntos

Anticorpos Monoclonais Humanizados/uso terapêutico; Imunoglobulina G/uso terapêutico; Subunidade alfa de Receptor de Interleucina-2/imunologia; Esclerose Múltipla/imunologia; Esclerose Múltipla/terapia; Daclizumabe; Humanos

Palavras-chave

Anti-CD25; Daclizumab; Immunomodulatory therapy; Monoclonal antibody treatment; Multiple sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Subunidade alfa de Receptor de Interleucina-2 / Anticorpos Monoclonais Humanizados / Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google